Casdin Capital’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.9M Buy
990,097
+89,314
+10% +$1.53M 1.54% 14
2025
Q1
$57.5M Sell
900,783
-172,717
-16% -$11M 4.7% 6
2024
Q4
$131M Hold
1,073,500
8.69% 4
2024
Q3
$134M Hold
1,073,500
8.94% 5
2024
Q2
$170M Buy
1,073,500
+4,500
+0.4% +$711K 12.95% 3
2024
Q1
$138M Buy
1,069,000
+62,500
+6% +$8.09M 10.29% 4
2023
Q4
$97.1M Sell
1,006,500
-3,830
-0.4% -$369K 9.53% 3
2023
Q3
$122M Sell
1,010,330
-4,670
-0.5% -$566K 13.55% 1
2023
Q2
$116M Sell
1,015,000
-145,000
-13% -$16.6M 10.16% 2
2023
Q1
$160M Sell
1,160,000
-155,000
-12% -$21.4M 13.17% 2
2022
Q4
$170M Buy
1,315,000
+90,000
+7% +$11.7M 13.2% 1
2022
Q3
$135M Buy
1,225,000
+575,000
+88% +$63.6M 8.9% 3
2022
Q2
$48.7M Sell
650,000
-150,000
-19% -$11.2M 4.12% 9
2022
Q1
$62.5M Sell
800,000
-550,000
-41% -$43M 2.8% 14
2021
Q4
$122M Buy
1,350,000
+250,000
+23% +$22.5M 3.43% 12
2021
Q3
$102M Buy
1,100,000
+215,000
+24% +$19.9M 2.53% 13
2021
Q2
$68.8M Buy
885,000
+335,000
+61% +$26M 1.75% 20
2021
Q1
$41M Buy
550,000
+20,000
+4% +$1.49M 1.22% 23
2020
Q4
$90.4M Hold
530,000
2.68% 13
2020
Q3
$74.4M Hold
530,000
3.33% 9
2020
Q2
$85M Sell
530,000
-140,000
-21% -$22.4M 5.03% 4
2020
Q1
$65.5M Hold
670,000
6.96% 2
2019
Q4
$86.5M Sell
670,000
-210,000
-24% -$27.1M 7.95% 1
2019
Q3
$66.3M Buy
880,000
+545,000
+163% +$41M 6.86% 5
2019
Q2
$50.9M Buy
335,000
+30,000
+10% +$4.56M 4.76% 8
2019
Q1
$36.4M Buy
305,000
+155,000
+103% +$18.5M 3.99% 13
2018
Q4
$16.4M Buy
150,000
+110,000
+275% +$12M 2.8% 16
2018
Q3
$6.46M Buy
+40,000
New +$6.46M 0.79% 29